Mirati Therapeutics Inc

NASDAQ:MRTX   3:08:16 PM EDT
136.58
-0.18 (-0.13%)
Earnings Announcements

Mirati Therapeutics Reports Third Quarter 2021 Financial Results And Recent Corporate Updates

Published: 11/08/2021 21:07 GMT
Mirati Therapeutics Inc (MRTX) - Mirati Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Updates.
Q3 Loss per Share $1.55.
Qtrly Total Revenue $71.8 Million Versus $11.4 Million.company Expects to Complete Adagrasib NDA Submission to FDA by End of 2021.
Revenue is expected to be $1.25 Million
Adjusted EPS is expected to be -$2.99

Next Quarter Revenue Guidance is expected to be $0.31 Million
Next Quarter EPS Guidance is expected to be -$3.30

More details on our Analysts Page.